Leadership
John McKinley
John has over three decades’ experience of board-level executive and NED chairman roles in private and publicly listed companies, government departments including public private industry partnerships in the UK and overseas. He has specialist expertise in diagnostic technologies, instruments and devices, particularly in highly infectious respiratory human and animal diseases, with a deep knowledge of translational population genomics and personalised medicine. John transitioned from a foundation career in corporate, commercial and licensing legal practice, the London insurance industry and ESG technologies to executive roles in global Life Science, biotechnology and environmental sector companies. Seasoned in engaging executives, shareholders and stakeholders at all levels of seniority, he articulates visions for business improvement and ESG aligning disparate parties towards common purposes and goals. As a result, he has launched and led a variety of companies from start-up to become publicly listed entities with robust ESG governance and expansive global commercial footprints. John’s insights into global healthcare policies, practical translational expertise and senior legal background will help guide Impex’s mission to become the global leader in next-generation breath diagnostics.
Santi Dominguez
Santi Dominguez is a business graduate-turned-entrepreneur. He co-founded companies in Spain and the UK, oversaw the acquisition of G.A.S. mbH, Imspex’s technology developer and manufacturer (a division of Imspex Diagnostics Ltd) and has sold a company to Chinese acquirers. Santi is a Board member for life science technology companies in Spain, UK, Germany and California. He is passionate about driving innovation through Volatile Organic Compound (VOC) analysis.
David Wilson
David Wilson brings over 30 years of international leadership in the diagnostics industry. His expertise spans mergers and acquisitions, business development, and global sales. David has held key roles at companies like Genzyme Corporation and Avacta Group Plc., where he drove strategic growth and innovation in diagnostics. His extensive background in public and private sectors strengthens Imspex’s mission to deliver cutting-edge solutions for clinical and industry testing needs. David’s vision and experience are pivotal to Imspex’s corporate and commercial growth.
Dr. Emma Brodrick
Emma is a Breath Analysis expert with deep-seated technical development of gas chromatography – ion mobility spectrometry (GC-IMS) for health, Life Sciences & industry testing. With analytical and clinical experience in the translation of GC-IMS technology from the laboratory into clinical settings. A skilled project co-ordinator for international multi-faceted R&D and grant-funded projects. Emma has been a valuable member of the team for 12 years.
Amber Jacobs
Amber has over a decades’ experience in healthcare and life sciences start ups specialising in primary PR, marketing and social media strategies and management. A skilled Business Development executive of Life Science and IVD Medical Diagnostics instruments and devices.
Lisa Davies
Lisa holds over 3 decades of experience in administration and finance working within the HMRC. Highly skilled in group administration and financial project coordination Lisa has been the backbone of Imspex for 10 years.